Track record · closed signal

Hims & Hers Health, Inc. (HIMS) — closed signal from January 4, 2026

Partial Published before the outcome was known, scored automatically when the window closed on April 4, 2026.

Predicted vs. what happened

HIMS price · publication thesis → realized outcomesplit-adjusted

$32.00 – $34.00Entry zone — fair-value band

$33.41Published — price the day we called it

$41.76Target — the price the thesis aimed for

$36.45Peak — highest point inside the window, not a realized return

$19.14Window close — end-of-window price, context only

What happened

Partial

Reached 36% of the predicted growth at its peak, without hitting the target.

Peak price

$36.45

peak on January 7, 2026 — not a realized return

Peak gain

+9.1%

peak, from the publication price

Window close

$19.14

end-of-window price, context only

Days to target

—

Window

January 4, 2026 – April 4, 2026

The thesis — published January 4, 2026

Predicted growth

+25%

over the measurement window

Target price

$41.76

the price the thesis aimed for

Entry zone

$32.00 – $34.00

the fair-value band we waited for

Price at publication

$33.41

published January 4, 2026

Confidence

61%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

HIMS is a high-risk, short-term idea based on market mood and big options activity. Lots of people have been positioning around the stock, and recent price weakness has some indicators suggesting a quick bounce is possible. Because the company's underlying picture is weak and price swings are large, make this a small, time-limited trade and cut losses quickly.

Primary drivers

Heavy options activity shows people are actively positioning
Recent price pullback looks near oversold, supporting a bounce
Strong negative sentiment can trigger a fast short-covering move
High volatility and weak fundamentals increase chance of failure

How it played out

HIMS: the target was not reached

Lyra published HIMS on January 4 at 33.41 as a high-risk, short-term idea. The thesis looked for 25% growth toward 41.76. It pointed to heavy options activity, a recent pullback that looked near oversold, negative sentiment that might set up a fast short-covering move, and high volatility with weak fundamentals.

The stock rose early, but only to 36.45 on January 7. That was a 9.1% peak gain, still below the target. It never got there. By April 4, HIMS ended at 19.14. The bounce happened, but the full thesis missed.

What happened during the window

On February 19, 2026, MarketWatch reported that Hims & Hers announced a $1.15 billion agreement to buy Eucalyptus, with about $240 million due at closing. On April 3, 2026, TechRadar reported that Hims & Hers disclosed unauthorized access to customer service tickets between February 4 and February 7, 2026.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All HIMS signals